SDGR Schrodinger

Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling Education

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, and two City University of New York (CUNY) institutions, New York City College of Technology (City Tech) and LaGuardia Community College (LaGuardia), today announced that they have been awarded a three-year, to develop experiential learning opportunities for students in the field of computational molecular modeling. The grant will help increase access for underrepresented students to industry-leading technology and paid internships to prepare them for careers in drug discovery.

Schrödinger and two academic collaborators City Tech and LaGuardia will use the funding to launch a collaborative initiative, Introducing Molecular Modeling Experiences to underRepresented StudEnts (IMMERSE). IMMERSE seeks to increase entry points into drug discovery careers by enhancing student participation at multiple levels on the pathway from community college to a four-year institution to the workforce.

As part of the IMMERSE initiative, Dr. Katherine Bay from Schrödinger’s education team will collaborate with Biology Professors Dr. Mai Zahran and Dr. Armando Solis from City Tech and Chemistry Professor Dr. Ian Alberts from LaGuardia to redesign course curricula to integrate current industry-driven practices and cloud-based laboratory exercises, as well as provide paid internship programs for underrepresented students in STEM. The three-year grant will support approximately 480 STEM associate degree students from LaGuardia, up to 240 Biomedical Informatics Bachelor's degree students from City Tech, and 30 Schrödinger interns.

“Schrödinger has a strong track record of building educational initiatives to support the growth and development of computational modelers at all stages of their career, and we are thrilled to launch this new initiative,” stated Katherine Bay, Ph.D., a leader within Schrödinger’s education team. “The IMMERSE initiative is designed to provide access, opportunity, and empowerment to diverse groups of students from CUNY to better equip the next generation of computational scientists with expertise and long-term connections that can lead to successful careers in molecular modeling.”

“City Tech's Biomedical Informatics program is among the first in the nation to offer a truly integrated Biomedical Informatics degree at the undergraduate level. Recognized by leaders in the field, the curriculum is crafted to provide comprehensive training in the use of vast biomedical databases in healthcare, pharmaceutical, biotech, and research settings,” stated Mai Zahran, Ph.D., Associate Professor at the New York City College of Technology and the lead Principal Investigator on the grant. “The IMMERSE initiative is a unique opportunity to offer students a direct path from their associate degree to baccalaureate degree and bridge the gap between classroom experiences and industry-relevant questions. We are very excited to partner with LaGuardia Community College and Schrödinger to help talented and diverse students acquire computational modeling skills that can lead to long, successful careers in science.”

​​“LaGuardia’s mission is to educate and graduate one of the most diverse student populations in the country. The college is renowned for providing experiential learning to traditionally disadvantaged students in order to enhance their innovative capabilities concerning industry-related issues,” stated Ian Alberts, Ph.D., Professor at LaGuardia Community College and co-Principal Investigator on the grant. “The IMMERSE initiative affords an unprecedented environment to empower associate degree students with molecular modeling skills that are key for the workforce. We are delighted to work closely with City Tech and Schrödinger to improve educational pathways and provide career opportunities in the biotechnology area.”

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has approximately 800 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit , follow us on and , or visit our blog, .

For more information about Schrödinger’s education programs and corporate sustainability initiatives, please visit the section of our website and read our .

About New York City College of Technology (City Tech)

City Tech, located at the foot of the Brooklyn Bridge in Downtown Brooklyn, is the designated college of technology within the City University of New York (CUNY). Founded in 1946, today City Tech is a national model for industry-aligned education and an engine for economic mobility, offering 58 cutting-edge associate and baccalaureate degree programs spanning the technologies of art and design, architecture, biomedical informatics, business, teacher education, computer systems, engineering, entertainment, health care, hospitality, human services, legal studies, and the liberal arts and sciences. As a Hispanic Serving Institution (HSI) and Asian American/Native American Pacific Island Serving Institution (AANAPISI), City Tech is committed to providing broad access to high quality technological and professional education for a diverse urban population. To learn more, visit.

About LaGuardia Community College

LaGuardia Community College (LAGCC), a Hispanic-Serving Institution, located in Long Island City, Queens offers more than 50 degrees and certificates, and more than 65 continuing education programs to educate New Yorkers seeking new skills and careers. As an institution of the City University of New York (CUNY), the College reflects the legacy of our namesake, Fiorello H. LaGuardia, the former NYC mayor beloved for his advocacy of underserved populations. Since 1971, LaGuardia’s academic programs and support services have advanced the socioeconomic mobility of students while providing them with access to a high quality, affordable college education. To learn more, visit .

EN
28/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Schrodinger

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c...

NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company’s common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 6,943 shares of the company’s common stock to seven newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made ...

 PRESS RELEASE

Schrödinger Expands Board of Directors with Appointment of Bridget van...

NEW YORK--(BUSINESS WIRE)-- , Inc. (Nasdaq: SDGR) today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025. This press release features multimedia. View the full release here: Bridget van Kralingen was appointed to Schrödinger’s Board of Directors in March 2025. (Photo: Business Wire) “Bridget has a proven track record of growing global software businesses, and we are pleased to welcome her to our Board,” said Ramy Farid, Ph.D., chief executive officer of Schrödinger. “Bridget’s leadership experience overseeing strategic initiatives at global ...

 PRESS RELEASE

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial...

NEW YORK--(BUSINESS WIRE)-- (Nasdaq: SDGR) today announced financial results for the fourth quarter and full-year ended December 31, 2024, and provided its financial outlook for 2025. “We are delighted with Schrödinger’s excellent financial performance in 2024. Software revenue growth exceeded our expectations, showing the resilience of our business through changing industry cycles and the impact of large contract renewals. Our drug discovery collaboration portfolio is expanding, driven by our new agreement with Novartis and expanded collaborations with Otsuka and Lilly, and we expect to re...

 PRESS RELEASE

Schrödinger to Participate in Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 45th Annual Health Care Conference: Fireside chat on Tuesday, March 4, 2025 at 10:30 a.m. E.T. Leerink Partners Global Biopharma Conference 2025: Fireside chat on Monday, March 10, 2025 at 3:40 p.m. E.T. KBCM Healthcare Forum: Fireside chat on Tuesday, March 18, 2025 at 9:00 a.m. E.T. The live discussions can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the even...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch